MRI scans gain attention as diagnostic tool for Alzheimer's detection

February 11, 2013 in Alzheimer's disease & dementia

(Medical Xpress)—Scientists can now detect early features of Alzheimer's disease using magnetic resonance imaging (MRI) scans.

In a study conducted by the Queensland Brain Institute (QBI) at The University of Queensland (UQ), researchers using MRI scans were able to detect loss of basal forebrain cholinergic neurons – an early and key feature of Alzheimer's disease.

Lead researcher Professor Elizabeth Coulson from QBI and her team used modeling techniques to observe the protein in the brain responsible for in the relevant region of the brain before the onset of Alzheimer's disease.

"The aim of this study was to determine whether loss of basal forebrain cholinergic neurons underpins changes, which can be detected through MRI using (DTI)," Professor Coulson said.

"By doing this, we were able to pinpoint significant signs of Alzheimer's onset, before the basal forebrain had actually deteriorated.

"Detecting cells before they die or degenerate gives opportunity for targeted intervention.

"It allows patients the opportunity to receive treatment to either reduce the effects or cease the onset of Alzheimer's."

Scientists are now looking to use DTI scans to detect these early signs of Alzheimer's in humans.

"These findings provide increased support for using DTI and probabilistic tractography as non-invasive tools for diagnosing and/or monitoring the progression of conditions affecting the integrity of the basal forebrain cholinergic system in humans, including Alzheimer's disease," Dr Coulson said.

The project will be published in NeuroImage, Volume 66, 1 February 2013, Pages 133–141.

More information: www.sciencedirect.… 19/66/supp/C

Journal reference: NeuroImage search and more info website

Provided by University of Queensland search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Drugs found to both prevent and treat Alzheimer's disease in mice

Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.

Alzheimer's disease & dementia created 6 hours ago | popularity 5 / 5 (2) | comments 0 | with audio podcast

Scientists identify molecular trigger for Alzheimer's disease

Researchers have pinpointed a catalytic trigger for the onset of Alzheimer's disease – when the fundamental structure of a protein molecule changes to cause a chain reaction that leads to the death of neurons ...

Alzheimer's disease & dementia created May 20, 2013 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Study finds that sleep apnea and Alzheimer's are linked

A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.

Alzheimer's disease & dementia created May 19, 2013 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Alzheimer's leaves bilingual victims stranded in Canada

The devastating effect of Alzheimer's disease on bilingual people has been thrown into focus in Canada, where the sudden loss of a second language can leave sufferers feeling like strangers in their own country.

Alzheimer's disease & dementia created May 19, 2013 | popularity not rated yet | comments 0

Study identifies new approach to improving treatment for MS and other conditions

(Medical Xpress)—Working with lab mice models of multiple sclerosis (MS), UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved ...

Alzheimer's disease & dementia created May 17, 2013 | popularity 5 / 5 (2) | comments 0 | with audio podcast


If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Antidepressant reduces stress-induced heart condition

A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.

Insight into the dazzling impact of insulin in cells

Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.